Skip to main content

Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism

  • Chapter
Calcium in Drug Actions

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 83))

Abstract

The bisphosphonates are a new class of drugs which have been developed in the past two decades for use in various diseases of bone, tooth, and calcium metabolism. Three are on the market today, while others are under clinical or preclinical investigation. This chapter will cover chemical and experimental aspects as well as clinical applications of these compounds. Literature is essentially limited to one reference, usually the original report. For two recent reviews, weighted somewhat differently and with more extensive references, see Fleisch (1983) and Francis and Martodam (1983).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ahrengart L, Lindgren U (1986) Prevention of ectopic bone formation by local application of ethane-1-hydroxy-1,1-diphosphonate (EHDP): an experimental study in rabbits. J Orthop Res 4:18–26

    PubMed  CAS  Google Scholar 

  • Altman RD, Johnston CC, Khairi MRA, Wellman H, Serafini AN, Sankey RR (1973) Influence of disodium etidronate on clinical and laboratory manifestations of Paget’s disease of bone (osteitis deformans). N Engl J Med 289:1379–1384

    PubMed  CAS  Google Scholar 

  • Anbar M, Newell GW, St John GA (1973) Fate and toxicity of orally administered polyethylene polyphosphonates. Food Cosmetics Tox 11:1001–1010

    CAS  Google Scholar 

  • Barbier A, Brelière JC, Paul RP, Roncucci R (1985) Comparative study of etidronate and SR 41319, a new diphosphonate, on passive cutaneous anaphylaxis and phospholipase A2 activity. Agents Actions 16:41–42

    PubMed  CAS  Google Scholar 

  • Barbier A, Brelière JC, Remandet B, Roncucci R (1986) Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate. Ann Rheum Dis 45:67–74

    PubMed  CAS  Google Scholar 

  • Barnett BL, Strickland LC (1979) Structure of disodium dihydrogen 1-hydroxyethylidene-diphosphonate tetrahydrate: a bone growth regulator. Acta Crystall B35:1212–1214

    CAS  Google Scholar 

  • Basle MF, Rebel A, Renier JC, Audran M, Filmon R, Malkani K (1984) Bone tissue in Paget’s disease treated by ethane-1-hydroxy-1,1 diphosphonate (EHDP). Clin Orthop Rel Res 184:281–288

    Google Scholar 

  • Bassett CAL, Donath A, Macagno F, Preisig R, Fleisch H, Francis MD (1969) Diphosphonates in the treatment of myositis ossificans. Lancet 2:845

    PubMed  CAS  Google Scholar 

  • Baumann JM, Bisaz S, Fleisch H, Wacker M (1978) Biochemical and clinical effects of ethane-1-hydroxy-1,1-diphosphonate on calcium nephrolithiasis. Clin Sci Mol Med 54:509–516

    PubMed  CAS  Google Scholar 

  • Baxter LA, DeLuca HF, Bonjour JP, Fleisch H (1974) Inhibition of vitamin D metabolism by ethane-1-hydroxy-1,1-diphosphonate. Arch Biochem Biophys 164:655–662

    PubMed  CAS  Google Scholar 

  • Beertsen W, Niehof A, Everts V (1985) Effects of 1-hydroxyethylidene-1,1-bisphosphonate (HEBP) on the formation of dentin and the periodontal attachment apparatus in the mouse. Am J Anat 174:83–103

    PubMed  CAS  Google Scholar 

  • Benedict JJ, Degenhardt CR, Perkins CM, Johnson KY, Bevan JA, Olson HM (1985 a) Cyclic geminal bis(phosphonates) as inhibitors of bone resorption. Calcif Tissue Int 38 [Suppl]:S31

    Google Scholar 

  • Benedict JJ, Johnson KY, Bevan JA, Perkins CM (1985 b) A structure/activity study of nitrogen heterocycle containing bis(phosphonates) as bone resorption inhibiting agents. Calcif Tissue Int 38 [Suppl]:S31

    Google Scholar 

  • Bevan JA, Johnson KY, Slough C, Benedict J, Fleisch H, Black J (1985) Skeletal effects of 2-(2-pyridinyl)-ethylidene-bis(phosphonate) in acute and subchronic rat studies. Calcif Tissue Int 38 [Suppl]:S31

    Google Scholar 

  • Bijvoet OLM, Frijlink WB, Jie K, Linden H van der, Meijer CJLM, Mulder H, Paassen HC van, Reitsma PH, Velde J te, Vries E de, Wey JP van der (1980) APD in Paget’s disease of bone. Role of the mononuclear phagocyte system? Arthritis Rheum 23:1193–1204

    PubMed  CAS  Google Scholar 

  • Bisaz S, Felix R, Fleisch H (1975 a) Quantitative determination of ethane-1-hydroxy-1,1-diphosphonate in urine and plasma. Clin Chim Acta 65:299–307

    PubMed  CAS  Google Scholar 

  • Bisaz S, Schenk R, Kunin AS, Russell RGG, Mühlbauer R, Fleisch H (1975 b) The comparative effects of vitamin D deficiency and ethane-1-hydroxy-1,1-diphosphonate administration on the histology and glycolysis of chick epiphyseal and articular cartilage. Calcif Tissue Res 19:139–152

    PubMed  CAS  Google Scholar 

  • Bisaz S, Jung A, Fleisch H (1978) Uptake by bone of pyrophosphate, diphosphonates and their technetium derivatives. Clin Sci Mol Med 54:265–272

    PubMed  CAS  Google Scholar 

  • Blaser B, Worms KH, Germscheid HG, Wollmann K (1971) Ueber 1-Hydroxyalkan-1,1-diphosphonsäuren. Z Anorg Allg Chem 381:247–259

    CAS  Google Scholar 

  • Bone HG, Zerwekh JE, Britton F, Pak CYC (1979) Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards. J Urol 121:568–571

    PubMed  Google Scholar 

  • Bonjour JP, Russell RGG, Morgan DB, Fleisch H (1973) Intestinal calcium absorption, Ca-binding protein, and Ca-ATPase in diphosphonate-treated rats. Am J Physiol 224:1011–1017

    CAS  Google Scholar 

  • Bonjour JP, Tröhler U, Preston C, Fleisch H (1978) Parathyroid hormone and renal handling of Pi: effect of dietary Pi and diphosphonates. Am J Physiol 234:F487–F505

    Google Scholar 

  • Bounameaux HM, Schifferli J, Montani JP, Jung A, Chatelanat F (1983) Renal failure associated with intravenous diphosphonate. Lancet 1:471

    PubMed  CAS  Google Scholar 

  • Boyce BF, Fogelman I, Ralston S, Smith L, Johnston E, Boyle IT (1984) Focal osteomalacia due to low-dose diphosphonate therapy in Paget’s disease. Lancet 1:821–824

    PubMed  CAS  Google Scholar 

  • Briner WW, Francis MD, Widder JS (1971) The control of dental calculus in experimental animals. Int Dent J 21:61–73

    PubMed  CAS  Google Scholar 

  • Canfield R, Rosner W, Skinner J, McWorther J, Resnick L, Feldman F, Kammerman S, Ryan K, Kunigonis M, Bohne W (1977) Diphosphonate therapy of Paget’s disease of bone. J Clin Endocrinol Metab 44:96–106

    PubMed  CAS  Google Scholar 

  • Casey PA, Casey G, Fleisch H, Russell RGG (1972) The effect of polyphloretin phosphate, polyestradiol phosphate, a diphosphonate and a polyphosphate on calcification induced by dihydrotachysterol in skin, aorta and kidney of rats. Experientia 28:137–138

    PubMed  CAS  Google Scholar 

  • Cecchini M, Felix R, Cooper PH, Fleisch H (1987) Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages. J Bone Min Res 2:135

    CAS  Google Scholar 

  • Cecchini M, Felix R, Cooper PH, Fleisch H (1987) Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages. J Bone Min Res 2:142

    Google Scholar 

  • Chambers TJ (1980) Diphosphonates inhibit bone resorption by macrophages in vitro. J Pathol 132:255–262

    PubMed  CAS  Google Scholar 

  • Chapuy MC, Meunier PJ, Alexandre CM, Vignon EP (1980) Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases. J Clin Invest 65:1243–1247

    PubMed  CAS  Google Scholar 

  • Chapuy MC, Charhon SA, Meunier PJ (1983) Sustained biochemical effects of short treatment of Paget’s disease of bone with dichloromethylene diphosphonate. Metab Bone Dis Rel Res 4:325–328

    CAS  Google Scholar 

  • Chester TL, Lewis EC, Benedict JJ, Sunberg RJ, Tettenhorst WC (1981) Determination of (dichloromethylene)diphosphonate in physiological fluids by ion-exchange chromatography with phosphorus-selective detection. J Chromatogr Sci 225:17–25

    CAS  Google Scholar 

  • Conrad KA, Lee SM (1981) Clodronate kinetics and dynamics. Clin Pharmacol Ther 30:114–120

    PubMed  CAS  Google Scholar 

  • Cram RL, Barmada R, Geho WB, Ray RD (1971) Diphosphonate treatment of calcinosis universalis. N Engl J Med 285:1012–1013

    PubMed  CAS  Google Scholar 

  • Curry JD, Nicholson DA (1972) Oligophosphonates. In: Griffith J, Grayson M (eds) Topics in phosphorus chemistry, vol 7. Wiley, New York, p 37

    Google Scholar 

  • Delaissé J-M, Eeckhout Y, Vaes G (1985) Biphosphonates and bone resorption: effects on collagenase and lysosomal enzyme excretion. Life Sci 37:2291–2296

    PubMed  Google Scholar 

  • Vries HR De, Bijvoet OLM (1974) Results of prolonged treatment of Paget’s disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP). Neth J Med 17:281–298

    PubMed  Google Scholar 

  • Vries E De, Weij JP van der, Veen CJP v d, Paassen HC van, Jager MJ, Sleeboom HP, Bijvoet OLM, Cats A (1982) In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of munonuclear phagocytes in lymphocyte proliferation. Immunology 47:157–163

    PubMed  Google Scholar 

  • Dewanjee MK, Didisheim P, Kaye MP, Solis E, Zollman PE, Francis MD, Torianni M, Trastek VS, Tago M, Edwards WD (1984) Platlet deposition on and calcification of bovine pericardial valve. Eur Heart J 5 [Suppl D]:1–5

    PubMed  CAS  Google Scholar 

  • Doty SB, Jones R, Finerman GA (1972) Diphosphonate influence on bone cell structure and lysosomal activity. J Bone Joint Surg 54:1128–1129

    Google Scholar 

  • Douglas DL, Russell RGG, Preston CJ, Prenton MA, Duckworth T, Kanis JA, Preston FE, Woodhead JS (1980) Effect of dichloromethylene diphosphonate in Paget’s disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease. Lancet 1:1043–1047

    PubMed  CAS  Google Scholar 

  • Drake GL, Calamari TA (1983) Industrial uses of phosphonates. In: Hilderbrand RL (ed) The role of phosphonates in living systems. CRC Press, Boca Raton, p 171

    Google Scholar 

  • Elomaa I, Blomqvist C, Gröhn P, Porkka L, Kairento AL, Seiander K, Lamberg-Allardt C, Holmström T (1983) Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. Lancet 1:146–149

    PubMed  CAS  Google Scholar 

  • Emonds-Alt X, Brelière J-C, Roncucci R (1985) Effects of 1-hydroxyethylidene-1,1 bisphosphonate and (chloro-4 phenyl) thiomethylene bisphosphonic acid (SR 41319) on the mononuclear cell factor-mediated release of neutral proteinases by articular chondrocytes and synovial cells. Biochem Pharmacol 34:4043–4049

    PubMed  CAS  Google Scholar 

  • Ende JJ (1979) Effects of some diphosphonates on the metabolism of bone in vivo and in vitro. Thesis, University of Leiden

    Google Scholar 

  • Engel R (1983) Phosphonic acids and phosphonates as antimetabolites. In: Hilderbrand RL (ed) The role of phosphonates in living systems. CRC Press, Boca Raton, p 97

    Google Scholar 

  • Eubank WB, Reeves RE (1982) Analog inhibitors for the pyrophosphate-dependent phosphofructokinase of Entamoeba histolytica and their effect of culture growth. J Parasitol 68:599–602

    PubMed  CAS  Google Scholar 

  • Evêquoz V, Trechsel U, Fleisch H (1985) Effect of bisphosphonates on production of interleukin 1-like activity by macrophages and its effect on rabbit chondrocytes. Bone 6:439–444

    PubMed  Google Scholar 

  • Fast DK, Felix R, Dowse C, Neumann WF, Fleisch H (1978) The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture. Biochem J 172:97–107

    PubMed  CAS  Google Scholar 

  • Felix R, Fleisch H (1979) Increase in alkaline phosphatase activity in calvaria cells cultured with diphosphonates. Biochem J 183:73–81

    PubMed  CAS  Google Scholar 

  • Felix R, Fleisch H (1981) Increase in fatty acid oxidation in calvaria cells cultured with diphosphonates. Biochem J 196:237–245

    PubMed  CAS  Google Scholar 

  • Felix R, Russell RGG, Fleisch H (1976) The effect of several diphosphonates on acid phosphohydrolases and other lysosomal enzymes. Biochim Biophys Acta 429:429–438

    PubMed  CAS  Google Scholar 

  • Felix R, Fast DK, Sallis JD, Fleisch H (1980) Effect of diphosphonate on glycogen content of rabbit ear cartilage cells in culture. Calcif Tissue Int 30:163–166

    PubMed  CAS  Google Scholar 

  • Felix R, Bettex JD, Fleisch H (1981) Effect of diphosphonates on the synthesis of prostaglandins in cultured calvaria cells. Calcif Tissue Int 33:549–552

    PubMed  CAS  Google Scholar 

  • Felix R, Guenther HL, Fleisch H (1984) The subcellular distribution of 14C dichloromethylenebisphosphonate and 14C 1-hydroxyethylidene-1,1-bisphosphonate in cultured calvaria cells. Calcif Tissue Int 36:108–113

    PubMed  CAS  Google Scholar 

  • Finerman GAM, Stover SL (1981) Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP. Metab Bone Dis Rel Res 4:337–342

    Google Scholar 

  • Fleisch H (1983) Bisphosphonates: mechanisms of action and clinical applications. In: Peck WA (ed) Bone and mineral research, annual 1. Excerpta Medica, Amsterdam, 319–357

    Google Scholar 

  • Fleisch H, Bisaz S (1962) Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 203:671–675

    PubMed  CAS  Google Scholar 

  • Fleisch H, Neuman WF (1961) Mechanisms of calcification: role of collagen, polyphosphates, and phosphatase. Am J Physiol 200:1296–1300

    CAS  Google Scholar 

  • Fleisch H, Russell RGG (1970) Pyrophosphate and polyphosphate. In: Encyclopaedia (Int) of pharmacology and therapeutics, section 51. Pharmacology of the endocrine system and related drugs. Pergamon, Oxford, p 61

    Google Scholar 

  • Fleisch H, Russell RGG, Straumann F (1966) Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212:901–903

    CAS  Google Scholar 

  • Fleisch H, Russell RGG, Francis MD (1969) Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 165:1262–1264

    PubMed  CAS  Google Scholar 

  • Fleisch H, Russell RGG, Bisaz S, Mühlbauer RC, Williams DA (1970) The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest 1:12–18

    PubMed  CAS  Google Scholar 

  • Flora L (1979) Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis. Arthritis Rheum 4:340–346

    Google Scholar 

  • Flora L, Hassing GS, Parfitt AM, Villanueva AR (1980) Comparative skeletal effects of two diphosphonates in dogs. Metab Bone Dis Rel Res 2:389–407

    Google Scholar 

  • Fogelman I, Smith L, Mazess R, Wilson MA, Bevan JA (1986) Absorption of oral disphosphonate in normal subjects. Clin Endocrinol 24:57–62

    CAS  Google Scholar 

  • Francis MD (1969) The inhibition of calcium hydroxyapatite crystal growth by polyphosphates. Calcif Tissue Res 3:151–162

    PubMed  CAS  Google Scholar 

  • Francis MD, Martodam RR (1983) Chemical, biochemical, and medicinal properties of the diphosphonates. In: Hilderbrand RL (ed) The role of phosphonates in living systems. CRC Press, Boca Raton, Florida, p 55

    Google Scholar 

  • Francis MD, Slough CL (1984) Acute intravenous infusion of disodium dihydrogen (1-hydroxyethylidene)diphosphonate: mechanism of toxicity. J Pharm Sci 73:1097–1100

    PubMed  CAS  Google Scholar 

  • Francis MD, Russell RGG, Fleisch H (1969) Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 165:1264–1266

    PubMed  CAS  Google Scholar 

  • Francis MD, Flora LF, King WF (1972) The effects of disodium ethane-1-hydroxy-1,1-diphosphonate on adjuvant induced arthritis in rats. Calcif Tissue Res 9:109–121

    PubMed  CAS  Google Scholar 

  • Fraser D, Russell RGG, Pohler O, Robertson WG, Fleisch H (1972) The influence of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats. Clin Sci 42:197–207

    PubMed  CAS  Google Scholar 

  • Frijlink WB, Velde J te, Bijvoet OLM, Heynen G (1979) Treatment of Paget’s disease with (3-amino-1-hydroxypropylidene)-1,1-Bisphosphonate (A.P.D.). Lancet 1:799

    PubMed  CAS  Google Scholar 

  • Gallagher JA, Guenther HL, Fleisch H (1982) Rapid intracellular degradation of newly synthesized collagen by bone cells. Effect of dichloromethylenebisphosphonate. Biochim Biophys Acta 719:349–355

    PubMed  CAS  Google Scholar 

  • Garattini S (1985) Bone resorption, metastasis, and diphosphonates. Monographs of the Mario Negri Institute for pharmacological research. Raven, New York

    Google Scholar 

  • Gasser AB, Morgan DB, Fleisch HA, Richelle LJ (1972) The influence of two diphosphonates on calcium metabolism in the rat. Clin Sci 43:31–45

    PubMed  CAS  Google Scholar 

  • Gebauer U, Russell RGG, Touabi M, Fleisch H (1976) Effect of diphosphonates on adenosine 3′:5′ cyclic monophosphate in mouse calvaria after stimulation by parathyroid hormone in vitro. Clin Sci Mol Med 50:473–478

    PubMed  CAS  Google Scholar 

  • Geho WB, Whiteside JA (1973) Experience with disodium etidronate in diseases of ectopic calcification. In: Frame B, Parfitt AM, Duncan H (eds) Clinical aspects of metabolic bone disease. Excerpta Medica, Amsterdam, p 506

    Google Scholar 

  • Grabenstetter RJ, Cilley WA (1971) Polynuclear complex formation in solutions of calcium ion and ethane-1-hydroxy-1,1-diphosphonic acid. I. Complexometric and pH titrations. J Phys Chem 75:676–682

    Google Scholar 

  • Guenther HL, Guenther HE, Fleisch H (1979) Effects of 1-hydroxyethane-1,1-diphosphonate and dichloromethane-diphosphonate on rabbit articular chondrocytes in culture. Biochem J 184:203–214

    PubMed  CAS  Google Scholar 

  • Guenther HL, Guenther HE, Fleisch H (1981 a) The effects of 1-hydroxyethane-1,1-di-phosphonate and dichloromethanediphosphonate on collagen synthesis by rabbit articular chondrocytes and rat bone cells. Biochem J 196:293–301

    PubMed  CAS  Google Scholar 

  • Guenther HL, Guenther HE, Fleisch H (1981 b) The influence of 1-hydroxyethane-1,1-diphosphonate and dichloromethanediphosphonate on lysine hydroxylation and crosslink formation in rat bone, cartilage and skin collagen. Biochem J 196:303–310

    PubMed  CAS  Google Scholar 

  • Guilland DF, Sallis JD, Fleisch H (1974) The effect of two diphosphonates on the handling of calcium by rat kidney mitochondria in vitro. Calcif Tissue Res 15:303–314

    PubMed  CAS  Google Scholar 

  • Guilland D, Trechsel U, Bonjour JP, Fleisch H (1975) Stimulation of calcium absorption and apparent increased intestinal, 1,25-dihydroxycholecalciferol in rats treated with low doses of ethane-1-hydroxy-1,1-diphosphonate. Clin Sci Mol Med 48:157–160

    PubMed  CAS  Google Scholar 

  • Guncaga J, Lauffenburger R, Lentner C, Dambacher MA, Haas HG, Fleisch H, Olah AJ (1974) Diphosphonate treatment of Paget’s disease of bone. A correlated metabolic, calcium kinetic and morphometric study. Horm Metab Res 6:62–69

    PubMed  CAS  Google Scholar 

  • Gural RP (1975) Pharmacokinetics and gastrointestinal absorption behavior of etidronate. Dissertation, University of Kentucky

    Google Scholar 

  • Hähnel H, Mühlbach R, Lindenhayn K, Schaetz P, Schmidt UJ (1973) Zum Einfluss von Diphosphonat auf die experimentelle Heparinosteopathie. Z Altersforsch 27:289–292

    Google Scholar 

  • Hansen NM Jr, Felix R, Bisaz S, Fleisch H (1976) Aggregation of hydroxyapatite crystals. Biochim Biophys Acta 451:549–559

    PubMed  CAS  Google Scholar 

  • Harvey RG, Sombre ER De (1964) The Michaelis-Arbuzov and related reactions. In: Grayson M, Griffith EJ (eds) Topics in phosphorus chemistry, vol I. 3. Wiley, New York, p 57

    Google Scholar 

  • Heaney RP, Saville PD (1976) Etidronate disodium in postmenopausal osteoporosis. Clin Pharmacol Ther 20:593–604

    PubMed  CAS  Google Scholar 

  • Hendlin D, Stapley EO, Jackson M, Wallick H, Miller AK, Wolf FJ, Miller TW, Chaiet L, Kahan FM, Foltz EL (1969) Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science 166:122–123

    PubMed  CAS  Google Scholar 

  • Henley JW, Croxson RS, Ibbertson HK (1979) The cardiovascular system in Paget’s disease of bone and the response to therapy with calcitonin and diphosphonate. Aust NZ J Med 9:390–397

    CAS  Google Scholar 

  • Heynen G, Delwaide P, Bijvoet OLM, Franchimont P (1982) Clinical and biological effects of low doses of (3 amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget’s disease of bone. Eur J Clin Invest 11:29–35

    Google Scholar 

  • Hilderbrand RL (1983) The effects of synthetic phosphonates on living systems. In: Hilderbrand RL (ed) The role of phosphonates in living systems. CRC Press, Boca Raton, p 139

    Google Scholar 

  • Hilderbrand RL, Henderson TO (1983) Phosphonic acids in nature. In: Hilderbrand RL (ed) The role of phosphonates in living systems. CRC Press, Boca Raton, p 5

    Google Scholar 

  • Hill LF, Lumb GA, Mawer EB, Stanbury SW (1973) Indirect inhibition of the biosynthesis of 1,25-dihydroxycholecalciferol in rats treated with a diphosphonate. Clin Sci 44:335–347

    PubMed  CAS  Google Scholar 

  • Hollander W, Prusty S, Nagraj S, Kirkpatrick B, Paddock J, Colombo M (1978) Comparative effects of cetaben (PHB) and dichloromethylene diphosphonate (Cl2MBP) on the development of atherosclerosis in the cynomolgus monkey. Atherosclerosis 31:307–325

    PubMed  CAS  Google Scholar 

  • Horiguchi M, Kandatsu M (1959) Isolation of 2-aminoethane phosphonic acid from rumen Protozoa. Nature 184:901–902

    PubMed  CAS  Google Scholar 

  • Jacobs TP, Siris ES, Bilezikian JP, Baquiran DC, Shane E, Canfield RE (1981) Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate. Ann Intern Med 94:312–316

    PubMed  CAS  Google Scholar 

  • Jee WSS, Black HE, Gotcher JE (1981) Effect of dichloromethane disphosphonate on cortisol-induced bone loss in young adult rabbits. Clin Orthop Rel Res 156:39–51

    CAS  Google Scholar 

  • Johnson KY, Wesseler MA, Olson HM, Martodam RR, Poser JW (1982) The effects of diphosphonates on tumor-induced hypercalcemia and osteolysis in Walker carcinosarcoma 256 (W-256) of rats. In: Donath A, Courvoisier B (eds) Diphosphonates and bone. Editions Médecine et Hygiène, Genève, p 386

    Google Scholar 

  • Johnston CC Jr, Altman RD, Canfield RE, Finerman GAM, Taulbee JD, Ebert ML (1983) Review of fracture experience during treatment of Paget’s disease of bone with etidronate disodium (EHDP). Clin Orthop 172:186–194

    PubMed  Google Scholar 

  • Jowsey J, Holley KE, Linman JW (1970) Effect of sodium etidronate in adult cats. J Lab Clin Med 76:126–133

    PubMed  CAS  Google Scholar 

  • Jowsey J, Riggs BL, Kelly PJ, Hoffman DL, Bordier P (1971) The treatment of osteoporosis with disodium ethane-1-hydroxy-1,1-diphosphonate. J Lab Clin Med 78:574–584

    PubMed  CAS  Google Scholar 

  • Jung A (1982) Comparison of two parenteral diphosphonates in hypercalcemia of malignancy. Am J Med 72:221–226

    PubMed  CAS  Google Scholar 

  • Jung A, Bisaz S, Fleisch H (1973) The binding of pyrophosphate and two diphosphonates on hydroxyapatite crystals. Calciv Tissue Res 11:269–280

    CAS  Google Scholar 

  • Jung A, Bornand J, Mermillod B, Edouard C, Meunier PJ (1984) Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. Cancer Res 44:3007–3011

    PubMed  CAS  Google Scholar 

  • Kaplan RA, Geho WB, Pointdexter C, Haussier M, Dietz GW, Pak CYC (1977) Metabolic effects of diphosphonate in primary hyperparathyroidism. J Clin Pharmacol 17:410–419

    PubMed  CAS  Google Scholar 

  • King WR, Francis MD, Michael WR (1971) Effect of disodium ethane-1-hydroxy-1,1-diphosphonate on bone formation. Clin Orthop 78:251–270

    PubMed  CAS  Google Scholar 

  • Komissarenko SV, Zhuravskii NI, Karlova NP, Gulyi MF (1977) Inhibition of hypersensitivity of delayed and immediate types in guinea pigs by methylenediphosphonic acid. Bull Exp Biol Med 84:1322–1323

    Google Scholar 

  • Kramsch DM, Chan CT (1978) The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous fatty plaques in rabbits. Circ Res 42:562–571

    PubMed  CAS  Google Scholar 

  • Labat ML, Tzehoval E, Moricard Y, Feldmann M, Milhaud G (1983) Lack of a T-cell dependent subpopulation of macrophages in (dichloromethylene) diphosphonate-treated mice. Biomed Pharmacother 37:270–276

    PubMed  CAS  Google Scholar 

  • Labat ML, Florentin I, Davigny M, Moricard Y, Milhaud G (1984) Dichloromethylene diphosphonate (Cl2MDP) reduces natural killer (NK) cell activity in mice. Metab Bone Dis Rel Res 5:281–287

    CAS  Google Scholar 

  • Lamson ML, Fox JL, Huguchi WI (1984) Calcium and 1-hydroxyethylidene-1,1-bisphos-phonic acid: polynuclear complex formation in the physiological range of pH. Int J Pharmaceut 21:143–154

    CAS  Google Scholar 

  • Larsson A (1974) The short-term effects of high doses of ethylene-1-hydroxy-1,1-diphosphonates upon early dentin formation. Calcif Tissue Res 16:109–127

    PubMed  CAS  Google Scholar 

  • Larsson SE (1976) The metabolic heterogeneity of glycosaminoglycans of the different zones of the epiphyseal growth plate and the effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) upon glycosaminoglycan synthesis in vivo. Calcif Tissue Res 21:67–82

    PubMed  CAS  Google Scholar 

  • Lenehan TM, Balligand M, Nunamaker DM, Wood FE Jr (1985) Effect of EHDP on fracture healing in dogs. J Orthop Res 3:499–507

    PubMed  CAS  Google Scholar 

  • Leonard EP, Reese WV, Mandel EJ (1979) Comparison of the effects of ethane-1-hydroxy-1,1-diphosphonate and dichloromethane diphosphonate upon periodontal bone resorption in rice rats. Arch Oral Biol 24:707–708

    PubMed  CAS  Google Scholar 

  • Levy RJ, Wolfrum J, Schoen FJ, Hawley MA, Lund SA (1985) Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate. Science 228:190–192

    PubMed  CAS  Google Scholar 

  • Liggett SJ (1973) Determination of ethane-1-hydroxy-1,1-diphosphonic acid (EHDP) in human feces and urine. Biochem Med 7:68–77

    PubMed  CAS  Google Scholar 

  • Lockwood DR, Vogel JM, Schneider VS, Hulley SB (1975) Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest. J Clin Endocrinol Metab 41:533–541

    PubMed  CAS  Google Scholar 

  • Martodam RR, Thornton KS, Sica DA, Souza SM, Flora L, Mundy GR (1983) The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor. Calcif Tissue Int 35:512–519

    PubMed  CAS  Google Scholar 

  • Metzger AL, Singer FR, Bluestone R, Pearson CM (1974) Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. N Engl J Med 291:1294–1296

    PubMed  CAS  Google Scholar 

  • Meunier P, Chapuy MC, Courpron P, Vignon E, Edouard C, Bernard J (1975) Effets cliniques, biologiques et histologiques de l’éthane-1-hydroxy-1,1-diphosphonate (EHDP) dans la maladie de Paget. Rev Rhum Mat Osteoartic 42:699–705

    CAS  Google Scholar 

  • Meunier PJ, Alexandre C, Edouard C, Mathieu L, Chapuy MC, Bressot C, Vignon E, Trechsel U (1979) Effects of disodium dichloromethylenediphosphonate on Paget’s disease of bone. Lancet 2:489–492

    PubMed  CAS  Google Scholar 

  • Meyer JL, Nancollas GH (1973) The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite. Calcif Tissue Res 13:295–303

    PubMed  CAS  Google Scholar 

  • Meyer JL, Lee KE, Bergert JH (1977) The inhibition of calcium oxalate crystal growth by multidentate organic phosphonates. Calcif Tissue Res 23:83–86

    PubMed  CAS  Google Scholar 

  • Michael WR, King WR, Wakim JM (1972) Metabolism of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey. Toxicol Appl Pharmacol 21:503–515

    PubMed  CAS  Google Scholar 

  • Milhaud G, Labat ML, Moricard Y (1983) (Dichloromethylene) diphosphonate-induced impairment of T-lymphocyte function. Proc Natl Acad Sci USA 80:4469–4473

    PubMed  CAS  Google Scholar 

  • Miller SC, Jee WSS (1979) The effect of dichloromethylenediphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat. Anat Rec 193:439–462

    PubMed  CAS  Google Scholar 

  • Minaire P, Bérard E, Meunier PJ, Edouard C, Goedert G, Pilonchéry G (1981) Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients. J Clin Invest 68:1086–1092

    PubMed  CAS  Google Scholar 

  • Morgan DB, Monod A, Russell RGG, Fleisch H (1973) Influence of dichloromethylene diphosphonate (Cl2MDP) and calcitonin on bone resorption, lactate production and phosphatase and pyrophosphatase content of mouse calvaria treated with parathyroid hormone in vitro. Calcif Tissue Res 13:287–294

    PubMed  CAS  Google Scholar 

  • Mühlbauer RC, Russell RGG, Williams DA, Fleisch H (1971) The effects of diphosphonates, polyphosphates, and calcitonin on immobilisation osteoporosis in rats. Eur J Clin Invest 1:336–344

    PubMed  Google Scholar 

  • Mühlemann HR, Bowles D, Schatt A, Bernimoulin JP (1970) Effect of diphosphonate on human supragingival calculus. Helv Odont Acta 14:31–33

    Google Scholar 

  • Nagant de Deuxchaisnes C, Rombouts-Lindemans C, Huaux JP, Devogelaer JP, Malghem J, Madlague B (1979) Roentgenologic evaluation of the action of the diphosphonate EHDP and of combined therapy (EHDP and calcitonin) in Paget’s disease of bone. Mol Endocrinol 1:405–433

    Google Scholar 

  • Nixon GA, Buehler EV, Newmann EA (1972) Preliminary safety assessment of disodium etidronate as an additive to experimental oral hygiene products. Toxicol Appl Pharmacol 22:661–671

    PubMed  CAS  Google Scholar 

  • Nolen GA, Buehler EV (1971) The effects of disodium etidronate on the reproductive functions and embryogeny of albino rats and New Zealand rabbits. Toxicol Appl Pharmacol 18:548–561

    PubMed  CAS  Google Scholar 

  • Ohata M, Pak CY (1974) Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate. Metabolism 23:1167–1173

    Google Scholar 

  • Ohya K, Yamada S, Felix R, Fleisch H (1985) Effect of bisphosphonates on prostaglandin synthesis by rat bone cells and mouse calvaria in culture. Clin Sci 69:403–411

    PubMed  CAS  Google Scholar 

  • Pilczyk R, Sutcliffe H, Martin TJ (1972) Effects of pyrophosphate and diphosphonates on parythyroid hormone- and fluoride-stimulated adenylate cyclase activity. FEBS Lett 24:225–228

    PubMed  CAS  Google Scholar 

  • Plasmans CMT, Kuypers W, Slooff TJJH (1978) The effect of ethane-1-hydroxy-1,1-diphosphonic acid (EHDP) on matrix induced ectopic bone formation. Clin Orthop Rel Res 132:233–243

    CAS  Google Scholar 

  • Plasmans CMT, Jap PHK, Kujipers W, Slooff TJJH (1980) Influence of diphosphonate on the cellular aspect of young bone tissue. Calcif Tissue Int 32:247–256

    PubMed  CAS  Google Scholar 

  • Pollard M, Luckert PH (1985) Effects of dichloromethylene diphosphonate on the osteolytic and osteoplastic effects of rat prostate adenocarcinoma cells. JNCI 75:949–954

    PubMed  CAS  Google Scholar 

  • Preston CJ, Yates AJP, Beneton MNC, Russell RGG, Gray RES, Smith R, Kanis JA (1986) Effective short term treatment of Paget’s disease with oral etidronate. Br Med J 292:79–80

    CAS  Google Scholar 

  • Rabens SF, Bethune JE (1975) Disodium etidronate therapy for dystrophic cutaneous calcification. Arch Dermatol 111:357–361

    PubMed  CAS  Google Scholar 

  • Radl J, Croese JW, Zurcher C, Enden-Vieveen MHM Van Den, Brondijk RJ, Kazil M, Haaijman JJ, Reitsma PH, Bijvoet OLM (1985) Influence of treatment with ADP-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer 55:1030–1040

    PubMed  CAS  Google Scholar 

  • Recker RR, Saville PD (1973) Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique. Toxicol Appl Pharmacol 24:580–589

    PubMed  CAS  Google Scholar 

  • Recker RR, Hassing GS, Lau JR, Saville PD (1973) The hyperphosphatemic effect of disodium ethane-1-hydroxy-1,1-diphosphonates (EHDPâ„¢): renal handling of phosphorus and the renal response to parathyroid hormone. J Lab Clin Med 81:258–266

    PubMed  CAS  Google Scholar 

  • Reiner M, Sautter V, Olah A, Bossi A, Largiadèr U, Fleisch H (1980) Diphosphonate treatment in myositis ossificans progressiva. In: Caniggia A (ed) Etidronate. Institute Gentili, Pisa, p 237

    Google Scholar 

  • Reitsma PH, Bijvoet OLM, Verlinden-Ooms H, Wee-Pals LJA van der (1980) Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxy-propylidene)-1,1-bisphosphonate (APD) in rats. Calcif Tissue Int 32:145–147

    PubMed  CAS  Google Scholar 

  • Reitsma PH, Teitelbaum SL, Bijvoet OLM, Kahn AJ (1982) Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro. J Clin Invest 70:927–933

    PubMed  CAS  Google Scholar 

  • Reynolds JJ, Minkin C, Morgan DB, Spycher D, Fleisch H (1972) The effect of two diphosphonates on the resorption of mouse calvaria in vitro. Calcif Tissue Res 10:302–313

    PubMed  CAS  Google Scholar 

  • Reynolds JJ, Murphy H, Mühlbauer RC, Morgan DB, Fleisch H (1973) Inhibition by diphosphonates of bone resorption in mice and comparison with grey lethal osteopetrosis. Calcif Tissue Res 12:59–71

    PubMed  CAS  Google Scholar 

  • Robertson WG, Peacock M, Nordin BEC (1973) Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 43:31–37

    PubMed  CAS  Google Scholar 

  • Rosenblum IY, Black HE, Ferrell JF (1977) The effects of various diphosphonates on a rat model of cardiac calciphylaxis. Calcif Tissue Res 23:151–159

    PubMed  CAS  Google Scholar 

  • Russell RGG, Mühlbauer RC, Bisaz S, Williams DA, Fleisch H (1970) The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats. Calcif Tissue Res 6:183–196

    PubMed  CAS  Google Scholar 

  • Russell RGG, Bisaz S, Donath A, Morgan DB, Fleisch H (1971) Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta and other disorders of bone. J Clin Invest 50:961–969

    PubMed  CAS  Google Scholar 

  • Russell RGG, Smith R, Preston C, Walton RJ, Woods CG (1974) Diphosphonates in Paget’s disease. Lancet 1:894–898

    PubMed  CAS  Google Scholar 

  • Ryzen E, Martodam RR, Troxell M, Benson A, Paterson A, Shepard K, Hicks R (1985) Intravenous etidronate in the management of malignant hypercalcemia. Arch Intern Med 145:449–452

    PubMed  CAS  Google Scholar 

  • Schenk R, Merz WA, Mühlbauer R, Russell RGG, Fleisch H (1973) Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196–214

    PubMed  CAS  Google Scholar 

  • Schenk R, Eggli P, Felix R, Fleisch H, Rosini S (1986) Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 38:342–349

    PubMed  CAS  Google Scholar 

  • Schibler D, Russell RGG, Fleisch H (1968) Inhibition of pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats. Clin Sci 35:363–372

    PubMed  CAS  Google Scholar 

  • Shane E, Baquiran DC, Bilezikian JP (1981) Effect of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism. Ann Intern Med 95:23–27

    PubMed  CAS  Google Scholar 

  • Shindoa H, Adamek G, Felix R, Fleisch H, Schenk R, Hagan P (1983) Structure-activity relationship of various bisphosphonates. Calcif Tissue Int 35:87–99

    Google Scholar 

  • Siris ES, Canfield RE, Jacobs TP, Baquiran DC (1980 a) Long-term therapy of Paget’s disease of bone with EHDP. Arthritis Rheum 23:1177–1183

    PubMed  CAS  Google Scholar 

  • Siris ES, Sherman WH, Baquiran DC, Schlatterer JP, Osserman EF, Canfield RE (1980 b) Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma. N Engl J Med 302:310–315

    PubMed  CAS  Google Scholar 

  • Siris ES, Hyman GA, Canfield R (1983) Effects of dichloromethylene diphosphonate in woman with breast carcinoma metastatic to the skeleton. Am J Med 74:401–406

    PubMed  CAS  Google Scholar 

  • Sleeboom HP, Bijvoet OLM, van Oosterom AT, Gleed JH, O’Riordan JLH (1983) Comparison of intravenous (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate and volume repletion in tumor-induced hypercalcemia. Lancet 2:239–243

    PubMed  CAS  Google Scholar 

  • Slooff TJJH, Feith R, Bijvoet OLM, Nollen AJG (1974) The use of a disphosphonate in para-articular ossification after total hip replacement. A clinical study. Acta Orthop Belg 40:820–828

    PubMed  CAS  Google Scholar 

  • Smith JD (1983) Metabolism of phosphonates. In: Hilderbrand RL (ed) The role of phos-phonates in living systems. CRC Press, Boca Raton, p 31

    Google Scholar 

  • Smith R, Russell RGG, Bishop M (1971) Diphosphonates and Paget’s disease of bone. Lancet 1:945–947

    PubMed  CAS  Google Scholar 

  • Spielman G, Gennarelli TA, Rogers CR (1983) Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. Arch Phys Med Rehabil 64:539–542

    PubMed  CAS  Google Scholar 

  • Steber J, Wierich P (1986) Properties of hydroxyethane disphosphonate affecting its environmental fate: degradability, sludge adsorption, mobility in soils, and bioconcentration. Chemosphere 15:929–945

    CAS  Google Scholar 

  • Steiner RM, Glassman L, Schwartz MW, Vanace P (1974) The radiological findings in dermatomyositis of childhood. Pediatr Radiol 111:385–393

    CAS  Google Scholar 

  • Stevenson PH, Stevenson JR (1986) Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages. Calcif Tissue Int 38:227–233

    PubMed  CAS  Google Scholar 

  • Stronski St A, Trechsel U, Fleisch H (1985) Plasma osteocalcin: lack of relation with bone resorption and effect of bisphosphonates in rats. Calcif Tissue Int 38 [Suppl]:S39

    Google Scholar 

  • Sturzenberger OP, Swancar JR, Reiter G (1971) Reduction of dental calculus in humans through the use of a dentifrice containing a crystal-growth inhibitor. J Periodontol 42:416–419

    PubMed  CAS  Google Scholar 

  • Stutzer A, Fleisch H, Trechsel U (1987 a) Long and short term effects of a single administration of bisphosphonates on retinoid induced bone resorption. J Bone Min Res 2 Suppl 1:416

    Google Scholar 

  • Stutzer A, Trechsel U, Fleisch H, Schenk R (1987 b) Effect of bisphosphonates on osteoclast number and bone resorption in the rat. J Bone Min Res 2 Suppl 1:266

    Google Scholar 

  • Thiébaud D, Jaeger P, Jacquet AF, Burckhardt P (1986) A single-day treatment of tumor-induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonate. J Bone Min Res 1:555–562

    Google Scholar 

  • Thomas BJ, Amstutz HC (1985) Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty. J Bone Joint Surg 67A:400–403

    Google Scholar 

  • Trechsel U, Schenk R, Bonjour JP, Russell RGG, Fleisch H (1977) Relation between bone mineralization, Ca absorption, and plasma Ca in phosphonate-treated rats. Am J Physiol 232:E298–E305

    PubMed  CAS  Google Scholar 

  • Troehler U, Bonjour JP, Fleisch H (1975) Renal secretion of diphosphonates in rats. Kidney Int 8:6–13

    PubMed  CAS  Google Scholar 

  • Van Breukelen FJM, Bijovet OLM, Oosterom AT (1979) Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (A.P.D.). Lancet 1:803–805

    PubMed  Google Scholar 

  • Van Breukelen FJM, Bijvoet OLM, Frijlink WB, Sleebloom HP, Mulder H, von Oosterom AT (1982) Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium. Calcif Tissue Int 34:321–327

    PubMed  Google Scholar 

  • Van Rooijen N, van Nieuwmegen R, Kamperdijk EWA (1985) Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate. Virchows Arch (Zel) 49:375–383

    Google Scholar 

  • Walton RJ, Russell RGG, Smith R (1975) Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man. J Clin Sci Mol Med 49:45–56

    CAS  Google Scholar 

  • Wasserman RH, Bonjour JP, Fleisch H (1973) Ileal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) and disodium dichloromethylene diphosphonate (Cl2MDP) in the chick. Experientia 29:1110–1111

    PubMed  CAS  Google Scholar 

  • Wiedmer WH, Zbinden AM, Trechsel U, Fleisch H (1983) Ultrafiltrability and chromatographic properties of pyrophosphate, 1-hydroxyethylidene-1,1-bisphosphonate, and dichloromethylenebisphosphonate in aqueous buffers and in human plasma. Calcif Tissue Int 35:397–400

    PubMed  CAS  Google Scholar 

  • Wingen F, Schmähl D (1985) Distribution of 3-amino-1-hydroxypropane-1,1-diphosphonic acid in rats and effects on rat osteosarcoma. Arzneimittelforsch 35:1565–1571

    PubMed  CAS  Google Scholar 

  • Wink CS, Onge MSt, Parker B (1985) The effects of dichloromethylene bisphosphonate on osteoporotic femora of adult castrate male rats. Acta Anat 124:117–121

    PubMed  CAS  Google Scholar 

  • Worms KH, Blum H (1979) Umsetzungen von 1-Aminoalkal-1,1-diphosphonsäuren mit salpetriger Säure. Z Anorg Allg Chem 457:209–213

    CAS  Google Scholar 

  • Worms KH, Schmidt-Dunker M (1976) Phosphonic acids and derivatives. In: Kosolapoff GM, Maier L (eds) Organic phosphorus compounds, vol 7. Wiley, New York, p 1

    Google Scholar 

  • Yakatan GJ, Poynor WJ, Talbert RL, Floyd BF, Slough CL, Ampulski RS, Benedict JJ (1982) Clodronate kinetics and bioavailability. Clin Pharmacol Ther 31:402–410

    PubMed  CAS  Google Scholar 

  • Yates AJP, Percival RC, Gray RES, Urwin GH, Hamdy NAT, Preston CJ, Beneton MNC, Russell RGG, Kanis JA (1985) Intravenous clodronate in the treatment and retreatment of Paget’s disease of bone. Lancet 1:1474–1477

    PubMed  CAS  Google Scholar 

  • Zernov IM, Stefani DV, Vel’tischev YE (1979) Assessment of the protective action of diphosphonate compound against damage to T-lymphocytes by antilymphocytic serum. Bull Exp Biol Med 87:253–254

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fleisch, H. (1988). Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism. In: Baker, P.F. (eds) Calcium in Drug Actions. Handbook of Experimental Pharmacology, vol 83. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71806-9_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71806-9_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71808-3

  • Online ISBN: 978-3-642-71806-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics